COVID-19 grips Olongapo City, kills 2 more seniors | Inquirer News

COVID-19 grips Olongapo City, kills 2 more seniors

SAN ANTONIO, Zambales—Two more elderly COVID-19 patients died in Olongapo on Sunday (May 2) as the city continued to grapple with fatalities from the disease caused by the coronavirus SARS Cov2.

In an advisory, Mayor Rolen Paulino Jr. said the latest to die of the disease were two men, aged 60 and 80, and both residents of the village of New Asinan.

The 80-year-old man was a government official but no other details were released about him except that he was hypertensive.

ADVERTISEMENT

Paulino also said the patient was hospitalized on April 16 after developing mild fever. Results of tests showed the man was positive for SARS Cov2.

FEATURED STORIES

The other fatality was a 60-year-old man who was diabetic and experienced chest pain and difficulty in breathing. He was declared dead on arrival at a private hospital.

Paulino said the two new deaths raised to 69 the total number of COVID-19 fatalities in the city.

In the last three days, COVID-19 had claimed the lives of at least four people in the city, all senior citizens.

So far, Olongapo has 175 active cases out of 1,512 infections recorded since 2020r. The city also registered 1,268 recoveries.

TSB

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: COVID-19, Diabetes, fatalities, hypertension, Olongapo City

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.